Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, September 19, 2025

Scientists reverse stroke damage with stem cells

 But is it the 'Paracrine Effect' or exosomes creating the benefits? If you don't know the answer, how do you make this repeatable on demand?
  • exosomes (61 posts to March 2011)
  • The "Paracrine Effect" is the best thing about Stem Cells May 2024

    The latest here:

    Scientists reverse stroke damage with stem cells

    Date:
    September 16, 2025
    Source:
    University of Zurich
    Summary:
    Scientists in Zurich have shown that stem cell transplants can reverse stroke damage by regenerating neurons, restoring motor functions, and even repairing blood vessels. The breakthrough not only healed mice with stroke-related impairments but also suggested that treatments could soon be adapted for humans, marking a hopeful step toward tackling one of the world’s most devastating conditions.
    FULL STORY

    Stem cell transplantation can reverse stroke damage, researchers at the University of Zurich report. Its beneficial effects include regeneration of neurons and restoration of motor functions, marking a milestone in the treatment of brain disorders.

    One in four adults suffer a stroke in their lifetime, leaving around half of them with residual damage such as paralysis or speech impairment because internal bleeding or a lack of oxygen supply kill brain cells irreversibly. No therapies currently exist to repair this kind of damage. "That's why it is essential to pursue new therapeutic approaches to potential brain regeneration after diseases or accidents," says Christian Tackenberg, the Scientific Head of Division in the Neurodegeneration Group at the University of Zurich (UZH) Institute for Regenerative Medicine.

    Neural stem cells have the potential to regenerate brain tissue, as a team led by Tackenberg and postdoctoral researcher Rebecca Weber has now compellingly shown in two studies that were conducted in collaboration with a group headed by Ruslan Rust from the University of Southern California. "Our findings show that neural stem cells not only form new neurons, but also induce other regeneration processes," Tackenberg says.

    New neurons from stem cells

    The studies employed human neural stem cells, from which different cell types of the nervous system can form. The stem cells were derived from induced pluripotent stem cells, which in turn can be manufactured from normal human somatic cells. For their investigation, the researchers induced a permanent stroke in mice, the characteristics of which closely resemble manifestation of stroke in humans. The animals were genetically modified so that they would not reject the human stem cells.

    One week after stroke induction, the research team transplanted neural stem cells into the injured brain region and observed subsequent developments using a variety of imaging and biochemical methods. "We found that the stem cells survived for the full analysis period of five weeks and that most of them transformed into neurons, which actually even communicated with the already existing brain cells," Tackenberg says.

    Brain regenerates itself

    The researchers also found other markers of regeneration: new formation of blood vessels, an attenuation of inflammatory response processes and improved blood-brain barrier integrity. "Our analysis goes far beyond the scope of other studies, which focused on the immediate effects right after transplantation," Tackenberg explains. Fortunately, stem cell transplantation in mice also reversed motor impairments caused by stroke. Proof of that was delivered in part by an AI-assisted mouse gait analysis.

    Clinical application moving closer to reality

    When he was designing the studies, Tackenberg already had his sights set on clinical applications in humans. That's why, for example, the stem cells were manufactured without the use of reagents derived from animals. The Zurich-based research team developed a defined protocol for that purpose in collaboration with the Center for iPS Cell Research and Application (CiRA) at Kyoto University. This is important for potential therapeutic applications in humans. Another new insight discovered was that stem cell transplantation works better when it is performed not immediately after a stroke but a week later, as the second study verified. In the clinical setting, that time window could greatly facilitate therapy preparation and implementation.

    Despite the encouraging results of the studies, Tackenberg warns that there is still work to be done. "We need to minimize risks and simplify a potential application in humans," he says. Tackenberg's group, again in collaboration with Ruslan Rust, is currently working on a kind of safety switch system that prevents uncontrolled growth of stem cells in the brain. Delivery of stem cells through endovascular injection, which would be much more practicable than a brain graft, is also under development. Initial clinical trials using induced stem cells to treat Parkinson's disease in humans are already underway in Japan, Tackenberg reports. "Stroke could be one of the next diseases for which a clinical trial becomes possible."

    No comments:

    Post a Comment